Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: the MOBILE study

C. Cooper; P. D. Delmas; D. Felsenberg; C. Hughes; N. Mairon; B. Bonvoisin; Jean-Yves Reginster

Back

Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: the MOBILE study

Conference proceeding

Peer reviewed

Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: the MOBILE study

C. Cooper, P. D. Delmas, D. Felsenberg, C. Hughes, N. Mairon, B. Bonvoisin and Jean-Yves Reginster

Annals of the Rheumatic Diseases, 64 (Suppl.III), 68 (2005-06); Congress of the European League Against Rheumatism (EULAR 2005), Vienna, Austria [AT], du 8 juin 2005 au 11 juin 2005

06/2005

Abstract

General & internal medicine

Human health sciences

Médecine générale & interne

Rheumatology

Rhumatologie

Sciences de la santé humaine

Metrics

1 Record Views

Details

Title: Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: the MOBILE study
Creators - without role: C. Cooper
P. D. Delmas
D. Felsenberg
C. Hughes
N. Mairon
B. Bonvoisin
Jean-Yves Reginster
Conference: Annals of the Rheumatic Diseases, 64 (Suppl.III), 68 (2005-06); Congress of the European League Against Rheumatism (EULAR 2005), Vienna, Austria [AT], du 8 juin 2005 au 11 juin 2005
Publisher: BMJ Group
Identifiers: 9952483608331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding